🔗 Visit the ClinicalTrials.gov page for NCT02215850
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting hypoxic response for cancer therapy. | Oncotarget | 2016 | 0.85 |
| 2 | Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis. | Front Oncol | 2016 | 0.85 |
| 3 | Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction. | Front Cell Dev Biol | 2016 | 0.84 |
| 4 | Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models. | Mol Cancer Ther | 2016 | 0.75 |
| 5 | Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer. | Dis Markers | 2016 | 0.75 |